Standardization of the Modified Rodnan Skin Score for Use in Clinical Trials of Systemic Sclerosis
University of Michigan · Scleroderma Foundation · +19 more institutions
Indexed incrossrefdatacitepubmed
Abstract
The modified Rodnan skin score (mRSS) is a measure of skin thickness and is used as a primary or secondary outcome measure in clinical trials of systemic sclerosis (scleroderma). This state-of-art review provides a historical perspective of the development of the mRSS, summarizes the performance of mRSS as an outcome measure, provides guidance on assessing mRSS, and makes recommendations for incorporation of the mRSS into clinical trials.
Citation impact
513
total citations
- FWCI
- 25.33
- Percentile
- 100%
- References
- 33
Citations per year
Authors
18- DKDinesh KhannaCorresponding
University of Michigan, Scleroderma Foundation
- DEDaniel E. Furst
University of California, Los Angeles
- PJPhilip J. Clements
University of California, Los Angeles
- YAYannick Allanore
Délégation Paris 5, Université Paris Cité, Hôpital Cochin
- MBMurray Baron
Jewish General Hospital, McGill University
Topics & keywords
Topics
Keywords
- Medicine
- Scleroderma (fungus)
- Clinical trial
- Standardization
- Measure (data warehouse)
- Progressive systemic sclerosis
- Medical physics
- Physical therapy
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.